Acceptability of Low Levels of Genotoxic Impurities in New Drug Substances: Case Reports

ISSN： 1364-9027

Source： International Journal of Pharmaceutical Medicine, Vol.18, Iss.4, 2004-01, pp. : 215-220

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Acceptability of Low Levels of Genotoxic Impurities in New Drug Substances: Conclusions of the Drug Information Association (DIA)/European Medicines Agency (EMEA) Workshop, October 27-28, 2003 in London, UK

By Peter Kasper

International Journal of Pharmaceutical Medicine, Vol. 18, Iss. 4, 2004-01 ,pp. : 221-223

Adis International

Access to resources Recommend Favorite

Assessment and Acceptance of Thresholds of Genotoxic Impurities in New Drug Substances: A Regulatory Perspective

By Peter Kasper

International Journal of Pharmaceutical Medicine, Vol. 18, Iss. 4, 2004-01 ,pp. : 209-214

Adis International

Access to resources Recommend Favorite

Setting Limits for Genotoxic Impurities in Drug Substances: Threshold-Based and Pragmatic Approaches

By David Kirkland

International Journal of Pharmaceutical Medicine, Vol. 18, Iss. 4, 2004-01 ,pp. : 197-207

Adis International

Access to resources Recommend Favorite

Case Reports and Drug Safety

By EP van Puijenbroek

Drug Safety, Vol. 29, Iss. 8, 2006-01 ,pp. : 643-645

Adis International

Access to resources Recommend Favorite

Fluconazole: Fixed drug eruptions: 5 case reports

Reactions Weekly, Vol. 1, Iss. 1186, 2008-01 ,pp. : 21-22

Adis International

Access to resources Recommend Favorite